Applied Genetic Technologies Corporation Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • April 2nd, 2021 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 2nd, 2021 Company Industry JurisdictionApplied Genetic Technologies Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: